Select Publications
Journal articles
2010, 'Early Effectiveness and Safety Results From the CoreValve Transcatheter Aortic Valve Australia-New Zealand Study', JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 56, pp. B112 - B113, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000209824200487&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2010, 'Long-term clinical outcomes with the next-generation Resolute Stent System: A report of the two-year follow-up from the RESOLUTE clinical trial', EuroIntervention, 5, pp. 692 - 697, http://dx.doi.org/10.4244/EIJV5I6A114
,2010, 'Guidelines for patient selection and performance of carotid artery stenting.', ANZ J Surg, 80, pp. 398 - 405, http://dx.doi.org/10.1111/j.1445-2197.2010.05330.x
,2009, 'Five-year clinical follow-up after implantation of the endeavor zotarolimus-eluting stent: ENDEAVOR I, first-in-human study', Catheterization and Cardiovascular Interventions, 74, pp. 989 - 995, http://dx.doi.org/10.1002/ccd.22206
,2009, 'Guidelines for patient selection and performance of carotid artery stenting', Journal of Medical Imaging and Radiation Oncology, 53, pp. 538 - 545, http://dx.doi.org/10.1111/j.1754-9485.2009.02120.x
,2008, 'Results of Percutaneous intervention in patients with Transplant Coronary Artery Disease: A Retrospective Analysis', Heart, Lung and Circulation, 17, pp. S180 - S180, http://dx.doi.org/10.1016/j.hlc.2008.05.427
,2008, 'Safety and efficacy of consecutive cycles of granulocyte-colony stimulating factor, and an intracoronary CD 133(+) cell infusion in patients with chronic refractory ischemic heart disease: The G-CSF in Angina patients with IHD to stimulate Neovascul', American Heart Journal, 156, pp. 954 - 963
,2007, 'Long-Term Clinical Follow-up of Sirolimus-Eluting (CYPHER™) Coronary Stents in the Treatment of InStent Restenosis in an Unselected Population', Heart Lung and Circulation, 16, pp. 440 - 446, http://dx.doi.org/10.1016/j.hlc.2007.02.090
,2007, 'Four-Year Clinical Follow-Up After Implantation of the Endeavor Zotarolimus-Eluting Stent: ENDEAVOR I, the First-in-Human Study', American Journal of Cardiology, 100, http://dx.doi.org/10.1016/j.amjcard.2007.08.023
,2007, 'Abstract 2669: The Use of Granulocyte-Colony Stimulating Factor in Angina Patients to Stimulate Neovascularization: the GAIN I study', Circulation, 116, http://dx.doi.org/10.1161/circ.116.suppl_16.ii_591-d
,2007, 'Adaptive bi-atrial pacing improves the maintenance of sinus rhythm', PACE - Pacing and Clinical Electrophysiology, 30, pp. 492 - 497, http://dx.doi.org/10.1111/j.1540-8159.2007.00698.x
,2007, 'Long-Term Follow-up of Renal Artery Stenting in an Australian Population', Heart Lung and Circulation, 16, pp. 79 - 84, http://dx.doi.org/10.1016/j.hlc.2006.12.008
,2007, 'The current status and future direction of percutaneous coronary intervention without on-site surgical backup: An expert consensus document from the Society for Cardiovascular Angiography and Interventions', Catheterization and Cardiovascular Interventions, 69, pp. 471 - 478, http://dx.doi.org/10.1002/ccd.21097
,2007, 'Actions and therapeutic potential of G-CSF and GM-CSF in cardiovascular disease', Journal of Molecular and Cellular Cardiology, 42, pp. 19 - 33
,2007, 'Clinical Follow-Up of Paclitaxel-Eluting (TAXUS) Sents for the Treatment of Saphenous Vein Graft Disease', Journal of Interventional Cardiology, 20 (4), pp. 258 - 264
,2007, 'Diagnostic Accuracy of CT Coronary Angiography Compared with Invasive Coronary Angiography: Initial Experience At St Vincent's Hospital, Sydney', Heart, Lung and Circulation, 16, pp. S55 - S55, http://dx.doi.org/10.1016/j.hlc.2007.06.141
,2006, 'Insertion of a Fenestrated Amplatzer Atrial Septostomy Device for Severe Pulmonary Hypertension', Heart Lung and Circulation, 15, pp. 275 - 277, http://dx.doi.org/10.1016/j.hlc.2006.02.002
,2006, 'Staged carotid artery stenting and coronary artery bypass graft surgery: Initial results from a single center', Catheterization and Cardiovascular Interventions, 67, pp. 142 - 148
,2005, 'Granulocyte-Colony Stimulating Factor Decreases Angina and Improves Exercise Capacity in Patients with Chronic Refractory ‘No Option’ Ischemic Heart Disease.', Blood, 106, pp. 4215 - 4215, http://dx.doi.org/10.1182/blood.v106.11.4215.4215
,2005, 'First-in-human study of the Endeavor ABT-578-eluting phosphorylcholine-encapsulated stent system in de novo native coronary artery lesions: Endeavor I Trial.', Eurointervention, 1, pp. 157 - 164
,2005, 'Prehydration alone is sufficient to prevent contrast-induced nephropathy after day-only angiography procedures - A randomised controlled trial', Heart Lung and Circulation, 14, pp. 245 - 251, http://dx.doi.org/10.1016/j.hlc.2005.06.007
,2005, 'Granulocyte-colony stimulating factor decreases angina and improves exercise capacity in patients with chronic refractory `no option` ischemic heart disease', Blood, 106, pp. 134B - 134B
,2005, 'Percutaneous carotid artery stenting: a strategy in evolution', Internal Medicine Journal, 35, pp. 143 - 150
,2005, 'Update on the use of stem cells for cardiac disease', Internal Medicine Journal, 35, pp. 348 - 356
,2004, 'Endeavor I `first in human` safety and efficacy study - 12-month clinical, angiographic, and intravascular ultrasound results', Circulation, 110, pp. 563 - 564
,2004, 'ENDEAVOR I safety and efficacy study: 12-month results', American Journal of Cardiology, 94, pp. 68E - 68E
,2004, 'HEART TRANSPLANT PATIENTS TREATED WITH SIROLIMUS IMMMUNOTHERAPY SHOW SIGNIFICANT REDUCTION IN THE PROGRESSION OF GRAFT VASCULOPATHY AT 2 YEARS', Transplantation, 78, pp. 160 - 160, http://dx.doi.org/10.1097/00007890-200407271-00421
,2004, 'Sirolimus from the time of heart transplantation - persistent protection from graft vasculopathy at 2 years', The Journal of Heart and Lung Transplantation, 23, pp. S106 - S107, http://dx.doi.org/10.1016/j.healun.2003.11.194
,2004, 'Sirolimus in de novo heart transplant recipients reduces acuterejection and prevents coronary artery disease at 2 years - Arandomized clinical trial', Circulation, 110, pp. 2694 - 2700
,2004, 'Sirolimus provides protection from graft vasculopathy at 2 years afterheart transplantation', American Journal of Transplantation, 4, pp. 281 - 281
,2003, 'Hypertrophic cardiomyopathy: State-of-the-art review, with focus on the management of outflow obstruction', Internal Medicine Journal, 33, pp. 521 - 529, http://dx.doi.org/10.1046/j.1445-5994.2003.00475.x
,2003, 'Rapamycin in cardiovascular medicine', Internal Medicine Journal, 33, pp. 103 - 109, http://dx.doi.org/10.1046/j.1445-5994.2003.00331.x
,2003, 'Angiographic regression of cardiac allograft vasculopathy after introducing sirolimus immunosuppression', Journal of Heart and Lung Transplantation, 22, pp. 1276 - 1279, http://dx.doi.org/10.1016/S1053-2498(02)01239-1
,2003, 'Abciximab therapy post elective coronary artry stenting does not prevent a troponin rise mediated by increased levels of platelet P-selectin an dplatelet-monocyte aggregates', Journal of Thrombosis and Haemostasis, pp. 1769 - 1769
,2002, 'Global cardiology and come to Australia: 14th world congress of cardiology, Sydney, 5-9 May 2002', Medical Journal of Australia, 177, pp. 473 - 475, http://dx.doi.org/10.5694/j.1326-5377.2002.tb04913.x
,2001, 'Coronary Angioplasty and Rotablator Atherectomy Trial (CARAT): Immediate and late results of a prospective multicenter randomized trial', Catheterization and Cardiovascular Interventions, 53, pp. 213 - 220, http://dx.doi.org/10.1002/ccd.1151
,2000, 'IL-8 is an angiogenic factor in human coronary atherectomy tissue', Circulation, 101, pp. 1519 - 1526, http://dx.doi.org/10.1161/01.CIR.101.13.1519
,2000, 'Blood speed imaging with an intraluminal array', IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control, 47, pp. 672 - 681, http://dx.doi.org/10.1109/58.842055
,2000, 'Left main coronary artery disease in a 40-year-old man receiving HIV protease inhibitors', Australian and New Zealand Journal of Medicine, 30, pp. 92 - 93, http://dx.doi.org/10.1111/j.1445-5994.2000.tb01066.x
,1999, 'Validation of risk adjustment models for in-hospital percutaneous transluminal coronary angioplasty mortality on an independent data set', Journal of the American College of Cardiology, 34, pp. 692 - 697, http://dx.doi.org/10.1016/S0735-1097(99)00266-1
,1999, 'Heparin after percutaneous intervention (HAPI): A prospective multicenter randomized trial of three heparin regimens after successful coronary intervention', Journal of the American College of Cardiology, 34, pp. 461 - 467, http://dx.doi.org/10.1016/S0735-1097(99)00195-3
,1998, 'Frequency, predictors, and appropriateness of blood transfusion after percutaneous coronary interventions', American Journal of Cardiology, 81, pp. 702 - 707, http://dx.doi.org/10.1016/S0002-9149(97)01018-7
,1997, 'Endoluminal stenting for unprotected left main stenosis in Takayasu's arteritis', Catheterization and Cardiovascular Diagnosis, 40, pp. 272 - 275, http://dx.doi.org/10.1002/(SICI)1097-0304(199703)40:3<272::AID-CCD11>3.0.CO;2-R
,1997, 'Gene-based therapies for restenosis', Advanced Drug Delivery Reviews, 24, pp. 109 - 120, http://dx.doi.org/10.1016/S0169-409X(96)00485-1
,1997, 'The role of proto-oncogenes in coronary restenosis', Progress in Cardiovascular Diseases, 40, pp. 117 - 128, http://dx.doi.org/10.1016/S0033-0620(97)80004-7
,1996, 'Percutaneous transhepatic mitral commissurotomy', Catheterization and Cardiovascular Diagnosis, 39, pp. 204 - 206, http://dx.doi.org/10.1002/(SICI)1097-0304(199610)39:2<204::AID-CCD22>3.0.CO;2-F
,1996, 'Facilitated advancement of the Palmaz-Schatz stent delivery system with the use of an adjacent 0.018' stiff wire', Catheterization and Cardiovascular Diagnosis, 39, pp. 106 - 110, http://dx.doi.org/10.1002/(SICI)1097-0304(199609)39:1<106::AID-CCD24>3.0.CO;2-G
,1996, 'Lesion-directed administration of alteplase with intracoronary heparin in patients with unstable angina and coronary thrombus undergoing angioplasty', Catheterization and Cardiovascular Diagnosis, 37, pp. 382 - 391, http://dx.doi.org/10.1002/(SICI)1097-0304(199604)37:4<382::AID-CCD8>3.0.CO;2-7
,1996, 'Safety and feasibility of liver-directed ex vivo gene therapy for homozygous familial hypercholesterolemia', Annals of Surgery, 223, pp. 116 - 126, http://dx.doi.org/10.1097/00000658-199602000-00002
,1996, 'Quantitative Doppler tissue imaging for assessment of regional myocardial velocities during transient ischemia and reperfusion', American Heart Journal, 132, pp. 721 - 725, http://dx.doi.org/10.1016/S0002-8703(96)90303-8
,